These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2768544)

  • 1. Trazodone treatment of bulimia nervosa.
    Solyom L; Solyom C; Ledwidge B
    J Clin Psychopharmacol; 1989 Aug; 9(4):287-90. PubMed ID: 2768544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A placebo-controlled study of trazodone in bulimia nervosa.
    Pope HG; Keck PE; McElroy SL; Hudson JI
    J Clin Psychopharmacol; 1989 Aug; 9(4):254-9. PubMed ID: 2671058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Psychoeducative ambulatory group in bulimia nervosa. Evaluation of a short-term approach].
    Fernández F; Sánchez I; Turón JV; Jiménez S; Alonso P; Vallejo J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(1):23-8. PubMed ID: 9549133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence of bulimia among secondary school students in Casablanca].
    Ghazal N; Agoub M; Moussaoui D; Battas O
    Encephale; 2001; 27(4):338-42. PubMed ID: 11686055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological treatment of kleptomania and bulimia nervosa.
    McElroy SL; Keck PE; Pope HG; Hudson JI
    J Clin Psychopharmacol; 1989 Oct; 9(5):358-60. PubMed ID: 2677062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year follow-up of psychosocial and pharmacologic treatments for bulimia nervosa.
    Agras WS; Rossiter EM; Arnow B; Telch CF; Raeburn SD; Bruce B; Koran LM
    J Clin Psychiatry; 1994 May; 55(5):179-83. PubMed ID: 8071266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder.
    Appolinario JC; Bacaltchuk J; Sichieri R; Claudino AM; Godoy-Matos A; Morgan C; Zanella MT; Coutinho W
    Arch Gen Psychiatry; 2003 Nov; 60(11):1109-16. PubMed ID: 14609886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Obesity, alexithymia, psychopathology and binge eating: a comparative study of 40 obese patients and 32 controls].
    De Chouly De Lenclave MB; Florequin C; Bailly D
    Encephale; 2001; 27(4):343-50. PubMed ID: 11686056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled comparison of family-based treatment and supportive psychotherapy for adolescent bulimia nervosa.
    le Grange D; Crosby RD; Rathouz PJ; Leventhal BL
    Arch Gen Psychiatry; 2007 Sep; 64(9):1049-56. PubMed ID: 17768270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of bulimia with fenfluramine and desipramine.
    Blouin AG; Blouin JH; Perez EL; Bushnik T; Zuro C; Mulder E
    J Clin Psychopharmacol; 1988 Aug; 8(4):261-9. PubMed ID: 3062043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ghrelin concentrations and cardiac vagal tone are decreased after pharmacologic and cognitive-behavioral treatment in patients with bulimia nervosa.
    Tanaka M; Nakahara T; Muranaga T; Kojima S; Yasuhara D; Ueno H; Nakazato M; Inui A
    Horm Behav; 2006 Aug; 50(2):261-5. PubMed ID: 16643914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a role for selective monoamine oxidase inhibitor therapy in bulimia nervosa? A placebo-controlled trial of brofaromine.
    Kennedy SH; Goldbloom DS; Ralevski E; Davis C; D'Souza JD; Lofchy J
    J Clin Psychopharmacol; 1993 Dec; 13(6):415-22. PubMed ID: 8120155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine versus trazodone in the treatment of outpatients with major depression.
    Debus JR; Rush AJ; Himmel C; Tyler D; Polatin P; Weissenburger J
    J Clin Psychiatry; 1988 Nov; 49(11):422-6. PubMed ID: 3053668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trazodone in benzodiazepine dependence.
    Ansseau M; De Roeck J
    J Clin Psychiatry; 1993 May; 54(5):189-91. PubMed ID: 8509349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gustatory and olfactory sensitivity in patients with anorexia and bulimia in the course of treatment.
    Aschenbrenner K; Scholze N; Joraschky P; Hummel T
    J Psychiatr Res; 2008 Dec; 43(2):129-37. PubMed ID: 18423668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of perturbed body image in eating disorders using the Body Shape Questionnaire].
    Lavoisy G; Guelfi JD; Vera L; Dardennes R; Rouillon F
    Encephale; 2008 Dec; 34(6):570-6. PubMed ID: 19081453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term therapy for depression with trazodone.
    Fabre LF; Feighner JP
    J Clin Psychiatry; 1983 Jan; 44(1):17-21. PubMed ID: 6337131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trazodone: alternative dose regimens and sleep.
    Wheatley D
    Pharmatherapeutica; 1984; 3(9):607-12. PubMed ID: 6374681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open trial of fluvoxamine in the treatment of bulimia nervosa.
    Ayuso-Gutierrez JL; Palazón M; Ayuso-Mateos JL
    Int J Eat Disord; 1994 Apr; 15(3):245-9. PubMed ID: 8199604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.